CVVT

CVVT is proud to announce that ten of its distinguished researchers have been recognised as Highly Cited Researchers 2025 by Clarivate. This prestigious honour highlights their exceptional contributions to the fields of microbiology and infectious diseases, reflected in the remarkable influence and high citation impact of their research. According to Clarivate, a total of 6,868 scholars from 60 countries and regions have been named Highly Cited Researchers in 2025. The recognition is awarded...

Researchers from the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) and the Department of Microbiology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with Sichuan University, have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers hope for more...

Join the Centre for Virology, Vaccinology, and Therapeutics (CVVT) as we unveil cutting-edge advancements in influenza vaccines, liver...